Sequential Global Statistical Tests: A Novel Method for Evaluating Primary, Secondary and Exploratory Variables in a Hierarchy with an Accumulated Evidence Approach

The high heterogeneity of AD results in low correlations between endpoints, making it more prone to misinterpretation of overall treatment effects than diseases with higher correlations. Expecting significance on all outcomes is likely at least partly responsible for the high failure rate in AD. Using an sGST addresses this concern, by statistically ensuring no double counting of results with highly correlated outcomes, and no underestimation of the evidence provided by nearly independent outcomes.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_105726
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sequential Global Statistical Tests: A Novel Method for Evaluating Primary, Secondary and Exploratory Variables in a Hierarchy with an Accumulated Evidence Approach

Suzanne Hendrix, Craig Mallinckrodt, Kent Hendrix, Samuel P. Dickson
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Sequential Global Statistical Tests: A Novel Method for Evaluating Primary, Secondary and Exploratory Variables in a Hierarchy with an Accumulated Evidence Approach

Suzanne Hendrix, Craig Mallinckrodt, Kent Hendrix, Samuel P. Dickson
article en

Abstract

The high heterogeneity of AD results in low correlations between endpoints, making it more prone to misinterpretation of overall treatment effects than diseases with higher correlations. Expecting significance on all outcomes is likely at least partly responsible for the high failure rate in AD. Using an sGST addresses this concern, by statistically ensuring no double counting of results with highly correlated outcomes, and no underestimation of the evidence provided by nearly independent outcomes.

Alzheimer s & DementiaVol. 21(S5)
TetraLogic Pharmaceuticals (United States) (US)
Quality Education
Openalex Percentile: Top 32%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.